Vitaminsupplementation bei Hämodialysepatienten - Ausgleich des Mangels an wasserlöslichen Vitaminen

Literatur

• 01 Sullivan JF . et al . The effect of dialysis on plasma and tissue levels of vitamin C.  Trans Am Soc Artif Intern Organs. 1972;  18 277-282
• 02 Stenvinkel P . et al . Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.  Kidney Int. 1999;  55 1899-911
• 03 Kang J.Y .   . The gastrointestinal tract in uremia.  Dig Dis Sci. 1993;  38 257-268
• 04 Friedman AN . Pharmacologic B-vitamin therapy for hyperhomocysteinemia in dialysis patients: has the time come?.  Nutr Clin Care. 2002;  5 20-24
• 05 Fissell RB . et al . International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).  Am J Kidney Dis. 2004;  44 293-299
• 06 Schupp N . et al . Benfotiamine reduces genomic damage in peripheral lymphocytes of hemodialysis patients.  Naunyn Schmiedebergs Arch Pharmacol. 2008;  378 283-291
• 07 Hammes HP . et al . Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.  Nat Med. 2003;  9 294-299
• 08 Muller D . et al . Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients.  Clin J Am Soc Nephrol. 2007;  2 1249-1254
• 09 Fehrman-Ekholm I . et al . Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and online hemodiafiltration or hemofiltration.  Scand J Urol Nephrol. 2008;  42 74-80
• 10 Thomalley PJ . et al . High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease.  Diabetologia. 2007;  50 2164-2170
• 11 Robinson K . et al . Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.  Circulation. 1996;  94 2743-2748
• 12 Dennis VW . Robinson K . Homocysteinemia and vascular disease in end-stage renal disease.  Kidney Int. 1996;  57 (Suppl 1) 11-17
• 13 McCully KS . Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.  Am J Pathol. 1969;  56 111-128
• 14 Herrmann W . Obeid R . Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients.  Clin Chem Lab Med. 2005;  43 1039-1047
• 15 Jungers P . et al . Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.  Nephrol Dial Transplant. 1999;  14 2903-2906
• 16 Spence JD . et al . Vitamin Intervention For Stroke Prevention trial: an efficacy analysis.  Stroke. 2005;  36 2404-2409
• 17 Bonaa KH . et al . Homocysteine lowering and cardiovascular events after acute myocardial infarction.  N Engl J Med. 2006;  354 1578-1588
• 18 Stopper H . et al . Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.  Nephrol Dial Transplant. 2008;  23 3272-3279
• 19 Dierkes J . et al . Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate.  Atherosclerosis. 2001;  158 161-164
• 20 Cano N . et al . ESPEN Guidelines on Enteral Nutrition: Adult renal failure.  Clin Nutr. 2006;  25 295-310
• 21 Locatelli F . Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure.  Nephrol Dial Transplant. 2004;  (Suppl 2) 1-47